Intravenous Tissue Plasminogen Activator as Provocateur of Myocardial Infarction

被引：2
作者：
Burlen, Jordan [1 ]
Cholin, Liza [1 ]
Ruzieh, Mohammed [2 ]
Dasa, Osama [2 ]
机构：
[1] Univ Louisville, Sch Med, Dept Internal Med, Louisville, KY 40292 USA
[2] Univ Toledo, Coll Med, Dept Internal Med, 2801 W Bancroft St, Toledo, OH 43606 USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2017年 / 24卷 / 04期
关键词：
ISCHEMIC-STROKE; THERAPY;
D O I：
10.1097/MJT.0000000000000494
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E489 / E490
页数：2
相关论文
共 50 条
[21]   Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator [J].
Bissig, David ;
Manjunath, Rashmi ;
Traylor, Brittany R. ;
Richman, David P. ;
Ng, Kwan L. .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (06) :E102-E104
[22]   Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients [J].
Satoru Takeuchi ;
Kojiro Wada ;
Kimihiro Nagatani ;
Naoki Otani ;
Hideo Osada ;
Hiroshi Nawashiro .
Acta Neurochirurgica, 2012, 154 :87-87
[23]   Does Mild Deficit for Patients with Stroke Justify the Use of Intravenous Tissue Plasminogen Activator? [J].
Hassan, Ameer E. ;
Zacharatos, Haralabos ;
Hassanzadeh, Bahareh ;
El-Gengaihy, Ahmed ;
AlKawi, Ammar ;
Shhadeh, Akram ;
Kirmani, Jawad F. .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2010, 19 (02) :116-120
[24]   Acute Central Retinal Artery Occlusion Treated with Intravenous Recombinant Tissue Plasminogen Activator [J].
Nowak, Richard J. ;
Amin, Hardik ;
Robeson, Kimberly ;
Schindler, Joseph L. .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08) :913.e5-913.e8
[25]   ROLE OF EMERGENCY TISSUE PLASMINOGEN ACTIVATOR IN ISCHEMIC STROKE [J].
Alhejaily, Mohammed Ahmed ;
Almutairi, Majed Meshal ;
Alzaidi, Ahmad Abdulghani ;
Alshehri, Fahad Abdullah Ali ;
Alaql, Abdulrahman Bader ;
Almalki, Muhammad Abdullah M. ;
Almasabi, Mohammed Ahmed ;
Alhamyani, Abdulmajeed Hamed ;
Abuhalimeh, Faisal Fawzi .
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01) :2667-2670
[26]   Smoking-Thrombolysis Paradox Recanalization and Reperfusion Rates After Intravenous Tissue Plasminogen Activator in Smokers With Ischemic Stroke [J].
Kufner, Anna ;
Nolte, Christian H. ;
Galinovic, Ivana ;
Brunecker, Peter ;
Kufner, Gerald M. ;
Endres, Matthias ;
Fiebach, Jochen B. ;
Ebinger, Martin .
STROKE, 2013, 44 (02) :407-413
[27]   Intravenous tissue plasminogen activator for ischemic stroke in early pregnancy dosed by actual body weight [J].
Peksa, Gary D. ;
Ostrem, Jamie ;
Davis, Teresa .
SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
[28]   Stroke in a Child Safely Treated with Intravenous Tissue Plasminogen Activator and Edaravone, a Free Radical Scavenger [J].
Baba, Haruhisa ;
Sugimori, Hiroshi ;
Nanishi, Etsuro ;
Nagata, Hazumu ;
Lee, Sooyoung ;
Kuwashiro, Takahiro ;
Hashizume, Makoto .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08) :903.e5-903.e8
[29]   Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: Initial Israeli experience [J].
Schwammenthal, Y ;
Drescher, MJ ;
Merzeliak, O ;
Tsabari, R ;
Bruk, B ;
Feibel, M ;
Hoffman, C ;
Bakon, M ;
Rotstein, Z ;
Chapman, J ;
Tanne, D .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (02) :70-74
[30]   Rapid Neurological Recovery after Intravenous Tissue Plasminogen Activator in Stroke: Prognostic Factors and Outcome [J].
Machumpurath, Bejoy ;
Davis, Stephen M. ;
Yan, Bernard .
CEREBROVASCULAR DISEASES, 2011, 31 (03) :278-283
12345